Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Impedimed Limited ( (AU:IPD) ) is now available.
Impedimed Limited announced the issuance of 942,353 ordinary fully paid shares to its non-executive directors as part of the Non-Executive Director Share Plan, covering 30% of director fees for the quarter ending March 31, 2025. This move is part of the company’s strategy to align the interests of its directors with shareholders, potentially impacting the company’s governance and financial structure.
More about Impedimed Limited
Impedimed Limited operates in the medical technology industry, focusing on developing and providing non-invasive medical devices. The company’s primary products are designed for the measurement and monitoring of fluid status and body composition, with applications in healthcare sectors such as oncology and cardiology.
YTD Price Performance: -50.0%
Average Trading Volume: 72,592
Technical Sentiment Signal: Buy
Current Market Cap: $44.05M
See more data about IPD stock on TipRanks’ Stock Analysis page.